08UE37Z
Supplement Retina, Right to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 8 Eye |
| Operation | U Supplement |
| Body Part | E Retina, Right |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment an eye structure that is still present and functioning, without replacing its core function. Common examples include patch grafting to reinforce a thinned or weakened sclera, placement of amniotic membrane grafts over the ocular surface to support healing, and augmentation of eyelid or orbital tissue with grafft material to correct volume deficits or support structural integrity.
These procedures are typically performed when a structure remains anatomically present and capable of function but needs additional support to withstand mechanical stress, promote healing, or maintain proper shape and position, distinguishing them from procedures where the original tissue is discarded and substituted. Supplement is often used alongside repair work, providing reinforcement to an area that has already been surgically addressed.
Anatomy & Axis Detail
Retina, Right
The right retina is the light-sensitive neural layer lining the back of the globe, and defects such as macular holes or large retinal tears can leave gaps that will not close with tamponade alone. Supplement in this location involves grafting material, such as an amniotic membrane or autologous tissue plug, into or over the defect to reinforce the retinal surface and promote closure during vitrectomy. This differs from simple repair because it adds biologic material that becomes a permanent structural part of the retina rather than merely realigning existing tissue. Surgeons select this approach for refractory or unusually large holes where standard techniques have failed. Documentation should specify the graft source and confirm the material remains in place as a structural addition.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign Supplement when documentation shows that material, whether autologous tissue, donor tissue, or synthetic substance, was added to reinforce or bulk up an existing structure, and it remains distinguishable from the code assigned for any concurrent Repair or other procedure performed on the same structure. Common documentation to look for includes amniotic membrane grafting for corneal or conjunctival surface support and scleral patch grafting for thinning or perforation risk.
A frequent mistake is coding a reinforcing graft as Replacement, when the native structure is not being taken over in function but simply bolstered, or as Repair, when actual material was added rather than the defect merely being closed with sutures. Coders should also verify whether the material used is documented clearly enough to support the correct device or substance value in the code.